Global Cell & Gene Therapy Cold Chain Logistics Market

View Report Summary
Global Cell and Gene Therapy Cold Chain Logistics Market
View Report Summary
Global cell & gene therapy cold chain logistics market was valued USD1316.93 million in 2021 and is anticipated to grow at CAGR of 14.29% during the forecast period. The global cell and gene therapy supply chain logistics market is driven by the growing geriatric population across the globe which is susceptible to various chronic diseases such as cancer, cardiovascular diseases, neurological disorders, among others. Additionally, factors such as growing prevalence of chronic diseases such as cancer, cardiovascular diseases, among others worldwide is further expected to support the market growth over the next few years. The growing number of cell & gene therapy clinical trials have significantly increased the demand for cell & gene therapy products and their transportation to different parts of the world, thereby positively influencing the growth of the global cell & gene therapy cold chain logistics market. For instance, in November 2021, there were around 179 active gene therapy clinical trials worldwide, out of which two were in the pre-clinical phase, 133 were in phase 1, 24 in phase 2, and 20 in phase 3. This number is expected to spike significantly in the coming years, thereby driving the demand for cold chain logistics. Global cell & gene therapy cold chain logistics market is segregated based on component, services offered, mode of transportation, holding temperature range, end user and region. Based on the component, market is segregated into cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment, and storage medium, cryogenic packout kits, others. By services offered, market is segmented into transportation, storage, and packaging. Holding temperature range is split into cryogenic, refrigerated, ambient, others. AmerisourceBergen Corporation (World Courier), United Parcel Service (Marken), Catalent, Inc., BioLife Solutions, Inc., Cryoport, Inc., together occupy for about 36.11% of the global cell & gene therapy cold chain logistics market.

 

captcha
Letters are not case-sensitive

     ( * Fields are mandatory)